Dr Ken Ishii | Professor and Project Leader
Osaka U.i | Japan

Dr Ken Ishii, Professor and Project Leader, Osaka U.i

Prof. Ken Ishii is currently appointed as Director for Vaccine and Adjuvant Research Center (CVAR) at National Institutes for Biomedical Innovation, Health and Nutrition (NIBIOHN) recently established by Ministry of Health, Labour and Welfare (MHLW) of Japanese government, as well as Professor of the Laboratory of Vaccine Science at the Immunology Frontier Research Center (IFREC), Osaka University in Japan. He is also affiliated as Science and Technology Advisor for Japan Agency for Medical Research and Development (AMED), Japan. Prof. Ishii graduated with a M.D. in 1993, practiced medicine for 4 years and then obtained a Ph.D. from the School of Medicine, Yokohama City University, Kanagawa, Japan. He is further qualified with his years of experience in vaccine research supported by numerous books and over 180 periodical publications over 20,000 citations since 1998 including 7 years as a Visiting Scientist and IND reviewer at US Food and Drug Administration (FDA) and 14 years in Osaka University and NIBIOHN. His H-index is 56 and elected as one of highly cited researchers for 3 years in raw (2014-16) by Thomson Reuters (Clarivate Analytics as of 2016). Based on his career, he conducts basic research on immunology related to vaccines and adjuvants and try to translate into vaccine markets globally.

Appearances:



DC Co-conference Day 2 April 4 @ 09:10

Novel adjuvants: What’s needed and how to get them approved?

  • Future of adjuvants – what is needed?
  • The need for a better strategy for a rational design
  • Developing adjuvants to improve existing vaccines & reduce the amount of vaccine antigen needed
  • New mechanism of adjuvant; Inducible adjuvant mediated by multiple, but specific pathways

back to speakers